The current FactSet consensus is for $63.22 billion in 2025 sales. Pfizer reiterated the 2024 outlook on Tuesday. The company said it sees adjusted earnings of $2.80 to $3 a share, while analysts ...

With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.

Pfizer’s CEO stated that the company revamped its commercial strategy, brought in new leadership, and exceeded market share expectations. On the cost side, Pfizer achieved $4 billion in savings ...

Pfizer’s CEO stated that the company revamped its commercial strategy, brought in new leadership, and exceeded market share expectations. On the cost side, Pfizer achieved $4 billion in savings and ...